当前位置: 首页 > 详情页

Effect of Normobaric Oxygen Therapy in a Rat Model of Intracerebral Hemorrhage

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Neuroprotection Research Laboratory, Departments of Neurology and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA [2]the Cerebrovascular Diseases Research Institute, Xuanwu Hospital, Capital Medical University, Beijing, China [3]the Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
出处:
ISSN:

关键词: acute stroke intracranial hemorrhage ischemia neuroprotection

摘要:
Background and Purpose-Normobaric oxygen (NBO) therapy may be neuroprotective in acute ischemic stroke. However, how NBO may affect intracerebral hemorrhage is unclear. We tested NBO in a rat model of striatal intracerebral hemorrhage. Methods-Intracerebral hemorrhage was induced by stereotactic injection of collagenase Type VII (0.5 U) into the right striatum of male Sprague-Dawley rats. One hour later, rats were randomized into controls (n = 13) versus NBO treatment (n = 13). NBO was applied for 2 hours. Hemorrhagic blood volume, brain water content, and neurological outcomes (forelimb placement test, forelimb asymmetry, neuroscore) were quantified at 72 hours. Experiments were repeated in a second independent laboratory to assess reproducibility in neurological outcomes (n = 10 per group). Results-NBO did not worsen hemorrhage severity or brain edema. There were no significant differences in hemorrhagic blood volumes (control, 6.4 +/- 0.9 mu L versus NBO, 7.0 +/- 2.1 mu L; P = 0.18) or brain water content (control, 81.9% +/- 1.1% versus NBO, 81.6% +/- 0.5%; P = 0.58). NBO did not affect any of the neurological outcome tests in the primary or secondary studies. Conclusions-NBO therapy may not worsen outcomes in intracerebral hemorrhage. (Stroke. 2011;42:1469-1472.)

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2010]版:
大类 | 1 区 医学
小类 | 1 区 临床神经病学 2 区 外周血管病
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 临床神经病学 1 区 外周血管病
JCR分区:
出版当年[2009]版:
Q1 PERIPHERAL VASCULAR DISEASE Q1 CLINICAL NEUROLOGY
最新[2023]版:
Q1 CLINICAL NEUROLOGY Q1 PERIPHERAL VASCULAR DISEASE

影响因子: 最新[2023版] 最新五年平均 出版当年[2009版] 出版当年五年平均 出版前一年[2008版] 出版后一年[2010版]

第一作者:
第一作者机构: [1]Neuroprotection Research Laboratory, Departments of Neurology and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
通讯作者:
通讯机构: [3]the Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院